Skip to content

CHEMBIO DIAGNOSTICS, INC.: 10-Q filed 2016-08-11

What CHEMBIO DIAGNOSTICS, INC. reported in its quarterly report filed 2016-08-11 (fiscal Q2 2016): 30 published measures, 88 facts as tagged in accession 0001092662-16-000192.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-11
Fiscal period
fiscal Q2 2016
Accession
0001092662-16-000192 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHEMBIO DIAGNOSTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-3012,689,279USD
At 2015-12-3120,816,344USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-303,527,210USD
At 2015-12-313,154,838USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-309,162,069USD
At 2015-12-3117,661,506USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-301,439,869USD
At 2015-12-315,376,931USD
At 2015-06-301,564,071USD
At 2014-12-314,614,538USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-8,347,482USD91
2016-01-01 to 2016-06-30-8,651,072USD182
2015-04-01 to 2015-06-30-664,085USD91
2015-01-01 to 2015-06-30-1,310,902USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-38,976,490USD
At 2015-12-31-30,325,418USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2016-04-01 to 2016-06-309,667,543shares91
2016-01-01 to 2016-06-309,649,612shares182
2015-04-01 to 2015-06-309,627,951shares91
2015-01-01 to 2015-06-309,623,773shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2016-04-01 to 2016-06-309,667,543shares91
2016-01-01 to 2016-06-309,649,612shares182
2015-04-01 to 2015-06-309,627,951shares91
2015-01-01 to 2015-06-309,623,773shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-0.86USD/shares91
2016-01-01 to 2016-06-30-0.9USD/shares182
2015-04-01 to 2015-06-30-0.07USD/shares91
2015-01-01 to 2015-06-30-0.14USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-0.86USD/shares91
2016-01-01 to 2016-06-30-0.9USD/shares182
2015-04-01 to 2015-06-30-0.07USD/shares91
2015-01-01 to 2015-06-30-0.14USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-04-01 to 2016-06-305,962,818USD91
2016-01-01 to 2016-06-305,800,818USD182
2015-04-01 to 2015-06-30-233,570USD91
2015-01-01 to 2015-06-30-461,070USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-302,035,666USD
At 2015-12-312,374,308USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-06-30146,265USD182
2015-01-01 to 2015-06-30195,591USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,385,974USD91
2016-01-01 to 2016-06-30-2,854,128USD182
2015-04-01 to 2015-06-30-897,971USD91
2015-01-01 to 2015-06-30-1,773,463USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-3010,361,581USD
At 2015-12-3112,634,806USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-06-304,579,553USD
At 2015-12-312,422,971USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-04-01 to 2016-06-303,966,279USD91
2016-01-01 to 2016-06-307,599,981USD182
2015-04-01 to 2015-06-303,917,103USD91
2015-01-01 to 2015-06-307,479,213USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-06-303,481,819USD
At 2015-12-313,578,025USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,580,305USD91
2016-01-01 to 2016-06-304,745,853USD182
2015-04-01 to 2015-06-303,019,132USD91
2015-01-01 to 2015-06-305,705,750USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,598,813USD91
2016-01-01 to 2016-06-303,598,217USD182
2015-04-01 to 2015-06-302,160,096USD91
2015-01-01 to 2015-06-304,137,670USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,367,466USD91
2016-01-01 to 2016-06-304,001,764USD182
2015-04-01 to 2015-06-301,757,007USD91
2015-01-01 to 2015-06-303,341,543USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-309,686,242shares
At 2015-12-319,628,248shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-06-3048,041,697USD
At 2015-12-3147,890,642USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-06-30860,340USD
At 2015-12-311,256,879USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,384,664USD91
2016-01-01 to 2016-06-30-2,850,254USD182
2015-04-01 to 2015-06-30-897,655USD91
2015-01-01 to 2015-06-30-1,771,972USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-01-01 to 2016-06-30580,159USD182
2015-01-01 to 2015-06-30665,672USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,310USD91
2016-01-01 to 2016-06-303,874USD182
2015-04-01 to 2015-06-30316USD91
2015-01-01 to 2015-06-301,491USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2016-01-01 to 2016-06-305,800,818USD182
2015-01-01 to 2015-06-30-461,070USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-302,156,582USD182
2015-01-01 to 2015-06-30528,642USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-96,206USD182
2015-01-01 to 2015-06-30143,405USD181

Inspect the source

Entity
CHEMBIO DIAGNOSTICS, INC. / CIK 0001092662
Captured
SEC response SHA-256
f4e40937d0d95fb11dba8f52939536a64af75af5fd3640d428deb7a120351716

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001092662.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))